Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Mortality Trends Across Non-Hodgkin Lymphoma Subtypes in Older Adults: A 25-Year CDC WONDER Analysis (1999-2024)

ABCL - 1303

Mortality Trends Across Non-Hodgkin Lymphoma Subtypes in Older Adults: A 25-Year CDC WONDER Analysis (1999-2024)

Aamer Ahmad

Poster Presenter: Aamer Ahmad

Thumbnail for Comparative Safety of Ibrutinib vs. Acalabrutinib in Chronic Lymphocytic Leukemia: A Propensity-Score-Matched Analysis of Real-World Outcomes

CLL - 1304

Comparative Safety of Ibrutinib vs. Acalabrutinib in Chronic Lymphocytic Leukemia: A Propensity-Score-Matched Analysis of Real-World Outcomes

Muhammad Usman Haider

Poster Presenter: Muhammad Usman Haider

Thumbnail for Prognostic Significance of tRNA Methyltransferase Expression in Intermediate-Risk Acute Myeloid Leukemia

Previous 1...104 105 106 107 108 109 110...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

AML - 1306

Prognostic Significance of tRNA Methyltransferase Expression in Intermediate-Risk Acute Myeloid Leukemia

Christine Wilson

Poster Presenter: Christine Wilson

Thumbnail for Real-World Incidence and Management of CRS and ICANS in Adults With Newly Diagnosed Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia Treated With Frontline TKI Plus Blinatumomab

ALL - 1307

Real-World Incidence and Management of CRS and ICANS in Adults With Newly Diagnosed Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia Treated With Frontline TKI Plus Blinatumomab

Rosa Ancaya

Poster Presenter: Rosa Ancaya

Thumbnail for Anticoagulation Safety and Thromboembolic Outcomes in Patients With Chronic Lymphocytic Leukemia and Atrial Fibrillation Receiving BTK Inhibitors: A Propensity-Matched TriNetX Analysis

CLL - 1309

Anticoagulation Safety and Thromboembolic Outcomes in Patients With Chronic Lymphocytic Leukemia and Atrial Fibrillation Receiving BTK Inhibitors: A Propensity-Matched TriNetX Analysis

Jude Ossai

Poster Presenter: Jude Ossai

Thumbnail for Cigarette Smoking and PFAS Exposure Are Associated With Higher Absolute Lymphocyte Count in Older US Adults: An NHANES Analysis With Implications for CLL and Monoclonal B-Cell Lymphocytosis

CLL - 1310

Cigarette Smoking and PFAS Exposure Are Associated With Higher Absolute Lymphocyte Count in Older US Adults: An NHANES Analysis With Implications for CLL and Monoclonal B-Cell Lymphocytosis

Maria Alejandra Molina Rodriguez

Poster Presenter: Maria Alejandra Molina Rodriguez

Thumbnail for Survival and Toxicity Outcomes With Hypomethylating Agent Plus Venetoclax vs Hypomethylating Agent Alone in Higher-Risk Myelodysplastic Syndrome: A Propensity-Matched Retrospective Cohort Study

MDS - 1311

Survival and Toxicity Outcomes With Hypomethylating Agent Plus Venetoclax vs Hypomethylating Agent Alone in Higher-Risk Myelodysplastic Syndrome: A Propensity-Matched Retrospective Cohort Study

Kumar Anmol

Poster Presenter: Kumar Anmol

Thumbnail for Clinical Outcomes of ETO Positive Acute Myeloid Leukemia: A Single-Center Experience From Pakistan

AML - 1312

Clinical Outcomes of ETO Positive Acute Myeloid Leukemia: A Single-Center Experience From Pakistan

Zara Tul Ain

Poster Presenter: Zara Tul Ain

$Thumbnail for Prior Bendamustine Exposure Within 12 Months and Outcomes After CAR-T or Bispecific Antibody Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Real-World Analysis$

ABCL - 1313

Prior Bendamustine Exposure Within 12 Months and Outcomes After CAR-T or Bispecific Antibody Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Real-World Analysis

Archit Srivastava

Poster Presenter: Archit Srivastava

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors